The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives
Open accessAbstract
Indole-3-carbinol (I3C) is produced by members of the family Cruciferae, and particularly members of the genus Brassica (e.g., cabbage, radishes, cauliflower, broccoli, Brussels sprouts, and daikon). Under acidic conditions, 13C is converted to a series of oligomeric products (among which 3,3'-diindolylmethane is a major component) thought to be responsible for its biological effects in vivo. In vitro, 13C has been shown to suppress the proliferation of various tumor cells including breast cancer, prostate cancer, endometrial cancer, colon cancer, and leukemic cells; induce G1/S arrest of the cell cycle, and induce apoptosis. The cell cycle arrest involves downregulation of cyclin D1, cyclin E, cyclin- dependent kinase (CDK)2, CDK4, and CDK6 and upregulation of p15, p21, and p27. Apoptosis by I3C involves downregulation antiapoptotic gene products, including Bcl-2, Bcl-xL, survivin, inhibitor-of-apoptosis protein (IAP), X chromosome-linked IAP (XIAP), and Fas-associated death domain protein-like interleukin-1-beta-converting enzyme inhibitory protein (FLIP); upregulation of proapoptotic protein Bax; release of micochondrial cytochrome C; and activation of caspase-9 and caspase-3. This agent inhibits the activation of various transcription factors including nuclear factor-kappaB, SP1, estrogen receptor, androgen receptor and nuclear factor-E2-related factor 2 (Nrf2). This indole potentiates the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through induction of death receptors and synergises with chemotherapeutic agents through downregulation of P-glycoprotein (P-gp). In vivo, I3C was found to be a potent chemopreventive agent for hormonal-dependent cancers such as breast and cervical cancer. These effects are mediated through its ability to induce apoptosis, inhibit DNA-carcinogen adduct formation, and suppress free-radical production, stimulate 2-hydroxylation of estradiol, inhibit invasion and angiogenesis. Numerous studies have indicated that I3C also has a strong hepatoprotective activity against various carcinogens. Initial clinical trials in women have shown that I3C is a promising agent against breast and cervical cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vegetables, Fruit, and Cancer Prevention
STEINMETZ, K. A., & POTTER, J. D. (1996) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(96)00273-8 · Cited by 2,118
Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C., & Bradfield, C. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9543 · Cited by 588
Bonnesen, C., Eggleston, I. M., & Hayes, J. D. (2001) · PubMed · Cited by 466
Chinni, S. R., Li, Y., Upadhyay, S., Koppolu, P. K., & Sarkar, F. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204365 · Cited by 315
Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice
Bradlow, H. L., Michnovicz, J. J., Telang, N. T., & Osborne, M. P. (1991) · Carcinogenesis · doi:10.1093/carcin/12.9.1571 · Cited by 304
Cover, C. M., Hsieh, S. J., Tran, S. H., Hallden, G., Kim, G. S., Bjeldanes, L. F., & Firestone, G. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3838 · Cited by 282
Placebo-Controlled Trial of Indole-3-Carbinol in the Treatment of CIN
Bell, M. C., Crowley-Nowick, P., Bradlow, H. L., Sepkovic, D. W., Schmidt-Grimminger, D., Howell, P., Mayeaux, E. J., Tucker, A., Turbat-Herrera, E. A., & Mathis, J. M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5847 · Cited by 262
Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.
Grubbs, C. J., Steele, V. E., Casebolt, T. L., Juliana, M. M., Eto, I., Lm, W., Dragnev, K. H., Kelloff, G. J., & Lubet, R. A. (1995) · PubMed · Cited by 237
Manson, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.9.1729 · Cited by 228
Chen, I., Safe, S., & Bjeldanes, L. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00060-3 · Cited by 222
Cited by
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis
HIGDON, J., DELAGE, B., WILLIAMS, D., & DASHWOOD, R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.009 · Cited by 1,039
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 709
Anticancer Efficacy of Polyphenols and Their Combinations
Niedzwiecki, A., Roomi, M., Kalinovsky, T., & Rath, M. (2016) · Nutrients · doi:10.3390/nu8090552 · Cited by 538
Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
NITULESCU, G. M., MARGINA, D., JUZENAS, P., PENG, Q., OLARU, O. T., SALOUSTROS, E., FENGA, C., SPANDIDOS, D. A., LIBRA, M., & TSATSAKIS, A. M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2015.3306 · Cited by 364
Hormetic Dietary Phytochemicals
Son, T. G., Camandola, S., & Mattson, M. P. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8037-y · Cited by 356
Lee, Y.-R., Chen, M., Lee, J. D., Zhang, J., Lin, S.-Y., Fu, T.-M., Chen, H., Ishikawa, T., Chiang, S.-Y., Katon, J., et al. (2019) · Science · doi:10.1126/science.aau0159 · Cited by 329
Indole-3-carbinol as a chemopreventive and anti-cancer agent
Weng, J.-R., Tsai, C.-H., Kulp, S. K., & Chen, C.-S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.033 · Cited by 327
Reactivity and Stability of Glucosinolates and Their Breakdown Products in Foods
Hanschen, F. S., Lamy, E., Schreiner, M., & Rohn, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402639 · Cited by 316
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806516200 · Cited by 311
Age-associated chronic diseases require age-old medicine: Role of chronic inflammation
Prasad, S., Sung, B., & Aggarwal, B. B. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2011.11.011 · Cited by 290
Self-citationAggarwal, B. B., Ichikawa, H., Garodia, P., Weerasinghe, P., Sethi, G., Bhatt, I. D., Pandey, M. K., Shishodia, S., & Nair, M. G. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.87 · Cited by 286
Self-citationCancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs
Safe, S., Papineni, S., & Chintharlapalli, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.021 · Cited by 269
Katz, E., Nisani, S., Yadav, B. S., Woldemariam, M. G., Shai, B., Obolski, U., Ehrlich, M., Shani, E., Jander, G., & Chamovitz, D. A. (2015) · The Plant Journal · doi:10.1111/tpj.12824 · Cited by 118
Saw, C. L.-L., Cintrón, M., Wu, T.-Y., Guo, Y., Huang, Y., Jeong, W.-S., & Kong, A.-N. T. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.759 · Cited by 118
Jędrejko, K., Lazarev, A., Jędrejko, M., & Muszyńska, B. (2024) · Food Reviews International · doi:10.1080/87559129.2023.2238055 · Cited by 4
Metadata
- Authors
- Aggarwal, B. B., & Ichikawa, H.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2005-07-06
- Volume
- 4
- Issue
- 9
- Pages
- 1201-1215
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2043620261
- Cited by
- 434
- References
- 71
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.